LFST vs. GH, RDNT, OPCH, SHC, BTSG, WGS, CON, SGRY, PRVA, and VCYT
Should you be buying LifeStance Health Group stock or one of its competitors? The main competitors of LifeStance Health Group include Guardant Health (GH), RadNet (RDNT), Option Care Health (OPCH), Sotera Health (SHC), BrightSpring Health Services (BTSG), GeneDx (WGS), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), Privia Health Group (PRVA), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.
LifeStance Health Group vs. Its Competitors
LifeStance Health Group (NASDAQ:LFST) and Guardant Health (NASDAQ:GH) are both mid-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, dividends, profitability and media sentiment.
LifeStance Health Group has higher revenue and earnings than Guardant Health. LifeStance Health Group is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.
LifeStance Health Group has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.45, indicating that its share price is 45% more volatile than the S&P 500.
LifeStance Health Group presently has a consensus target price of $8.50, indicating a potential upside of 54.83%. Guardant Health has a consensus target price of $58.24, indicating a potential downside of 2.03%. Given LifeStance Health Group's higher possible upside, equities research analysts plainly believe LifeStance Health Group is more favorable than Guardant Health.
LifeStance Health Group has a net margin of -1.23% compared to Guardant Health's net margin of -49.93%. Guardant Health's return on equity of 0.00% beat LifeStance Health Group's return on equity.
85.5% of LifeStance Health Group shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 6.6% of LifeStance Health Group shares are owned by insiders. Comparatively, 6.1% of Guardant Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
In the previous week, Guardant Health had 16 more articles in the media than LifeStance Health Group. MarketBeat recorded 23 mentions for Guardant Health and 7 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 1.28 beat Guardant Health's score of 1.17 indicating that LifeStance Health Group is being referred to more favorably in the media.
Summary
LifeStance Health Group and Guardant Health tied by winning 8 of the 16 factors compared between the two stocks.
Get LifeStance Health Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFST and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding LFST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
LifeStance Health Group Competitors List
Related Companies and Tools
This page (NASDAQ:LFST) was last updated on 9/10/2025 by MarketBeat.com Staff
Free LFST Stock Alerts